Metolazone Use in Congestive Heart Failure with Low eGFR

Introduction to Metolazone Therapy

• The European Society of Cardiology recommends metolazone for patients with severe CHF who have insufficient response to loop diuretics alone 1, 2
• Metolazone produces a synergistic effect with loop diuretics through sequential nephron blockade, enhancing diuresis in refractory fluid overload 3

Dosing and Monitoring of Metolazone

• The American Heart Association suggests starting with a low dose of metolazone (2.5 mg) when adding to the existing furosemide regimen 2
• Administer metolazone 30 minutes before the loop diuretic to maximize sequential nephron blockade 3
• Frequent monitoring is essential - check serum creatinine and electrolytes 5-7 days after initiation and after any dose adjustment 1, 2

Patient Management and Outcome Assessment

• Monitor weight daily to assess effectiveness of the combination therapy 4
• Check serum potassium, sodium, and renal function within 5-7 days of starting metolazone 1, 2
• Target weight loss of 0.5-1.0 kg daily to avoid too rapid diuresis 4

Safety Precautions and Potential Complications

• Avoid simultaneous initiation of ACE inhibitors and metolazone due to risk of profound hypotension 1
• Do not use potassium-sparing diuretics when initiating metolazone therapy 1
• Avoid excessive diuresis leading to volume contraction, which can worsen renal function and cause hypotension 4